Nono Incis A Biotechnology Company Based In Torontoontariocanadafounded In 2003The Company Focuses On Drug Development And Manufacturingspecifically Targeting Significant Health Challenges Related To Stroke Recoverywith A Mission To Assist Stroke Survivors Living With Permanent Disabilitiesnono Incaims To Enhance Their Quality Of Life Through Innovative Treatments One Of The Key Products In Development Is Nono 42Designed For The Treatment Of Acute Ischemic Strokethe Company Has Begun A First In Human Phase 1 Study To Assess The Safety And Efficacy Of This Treatmentnono Incgenerates Approximately $8 Million In Revenue And Employs Around 96 Peoplereflecting A Dedicated Team Committed To Its Mission Of Improving Outcomes For Stroke Survivors
No conferences found for this company.
| Company Name | Nono Inc |
| Country |
United States
|
| Address | 479A Wellington Street West Toronto Ontario Canada M5V 1E7 |
| Telephone | Login to View |
| Login to View |
